SCHEMBL17599372

SCHEMBL17599372

Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccc(-c3cccc(C(=O)O)c3F)c3ccccc23)c1C

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.62
▸ HSD17B10 Q99714 5/20 0.62
▸ HPGD P15428 4/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ KDM4E B2RXH2 2/20 0.62
▸ CRHBP P24387 1/20 0.62
▸ CRHR2 Q13324 1/20 0.62
▸ KEAP1 Q14145 4/20 0.48
▸ NFE2L2 Q16236 1/20 0.48
▸ FABP4 P15090 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MCL1 Q07820 3/20 0.43
▸ FABP5 Q01469 1/20 0.42
▸ BRD4 O60885 1/20 0.42
▸ ACLY P53396 1/20 0.41
▸ METAP2 P50579 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599352 0.88 ALDH1A1 (0.63) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599463 0.86 ALDH1A1 (0.57) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599358 0.82 ALDH1A1 (0.58) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599370 0.81 ALDH1A1 (0.53) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599329 0.78 KMT2A (0.55) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599324 0.74 MEN1 (0.47) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599423 0.72 ALDH1A1 (0.56) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599335 0.72 KEAP1 (0.47) ALDH1A1MEN1KMT2AKEAP1GAA
SCHEMBL17599363 0.71 MEN1 (0.53) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL17599414 0.71 KEAP1 (0.56) ALDH1A1HSD17B10HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback